Cristina Fernandez-Valle
Affiliations: | University of Central Florida, Orlando, FL, United States |
Area:
Molecular Biology, Neuroscience BiologyGoogle:
"Cristina Fernandez-Valle"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fernandez-Valle C, Nagel A, Huegel J, et al. (2023) Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis. Research Square |
| Hardin HM, Dinh CT, Huegel J, et al. (2023) Co-targeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells. Molecular Cancer Therapeutics |
| Huegel J, Dinh CT, Martinelli M, et al. (2022) CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells. Oncotarget. 13: 890-904 |
| Chang LS, Oblinger JL, Smith AE, et al. (2021) Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK. Plos One. 16: e0252048 |
| Ein L, Bracho O, Mei C, et al. (2019) Inhibition of tropomyosine receptor kinase B on the migration of human Schwann cell and dispersion of oral tongue squamous cell carcinoma in vitro. Head & Neck |
| Pestoni JC, Klingeman Plati S, Valdivia Camacho OD, et al. (2019) Peroxynitrite supports a metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival. The Journal of Biological Chemistry |
| Fuse MA, Dinh CT, Vitte J, et al. (2019) Preclinical Assessment of MEK1/2 Inhibitors for Neurofibromatosis Type 2-Associated Schwannomas Reveal Differences in Efficacy and Drug Resistance Development. Neuro-Oncology |
| Perez ER, Bracho O, Ein L, et al. (2018) Fluorescent Detection of Merlin-deficient Schwann Cells and Primary Human Vestibular Schwannoma Cells Using Sodium Fluorescein. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology |
| Allaway R, Angus SP, et al. (2018) Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2. Plos One. 13: e0197350 |
| Dinh CT, Bracho O, Mei C, et al. (2018) A Xenograft Model of Vestibular Schwannoma and Hearing Loss. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology |